Ingalls & Snyder »

Corcept Therapeutics Incorporated shares owned by Ingalls & Snyder

Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Ingalls & Snyder from 13F filings

Historical chart of Ingalls & Snyder investment in Corcept Therapeutics Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Corcept Therapeutics Incorporated held by Ingalls & Snyder consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corcept Therapeutics Incorporated by Ingalls & Snyder

Quarter filed Position value Share count Share price at filing
2024-09-30 $383M 8.3M 46.26
2024-06-30 $268M 8.2M 32.50
2024-03-31 $210M 8.3M 25.33
2023-12-31 $271M 8.4M 32.48
2023-09-30 $227M 8.3M 27.25
2023-06-30 $186M 8.4M 22.25
2023-03-31 $181M 8.4M 21.66
2022-12-31 $139M 6.8M 20.31
2022-09-30 $178M 7.0M 25.64
2022-06-30 $166M 7.0M 23.78
2022-03-31 $156M 6.9M 22.52
2021-12-31 $133M 6.7M 19.80
2021-09-30 $139M 7.1M 19.68
2021-06-30 $156M 7.1M 22.00
2021-03-31 $165M 6.9M 23.79
2020-12-31 $191M 7.3M 26.16
2020-09-30 $130M 7.5M 17.41
2020-06-30 $128M 7.6M 16.82
2020-03-31 $95M 8.0M 11.89
2019-12-31 $97M 8.0M 12.10
2019-09-30 $123M 8.7M 14.14
2019-06-30 $95M 8.5M 11.15
2019-03-31 $98M 8.4M 11.74
2018-12-31 $112M 8.4M 13.35
2018-09-30 $118M 8.4M 14.00
2018-06-30 $115M 7.3M 15.72
2018-03-31 $112M 6.8M 16.45
2017-12-31 $125M 6.9M 18.06
2017-09-30 $133M 6.9M 19.30
2017-06-30 $86M 7.3M 11.80
2017-03-31 $86M 7.8M 10.96
2016-12-31 $59M 8.2M 7.26
2016-09-30 $56M 8.6M 6.50
2016-06-30 $50M 9.2M 5.46